296 related articles for article (PubMed ID: 30194296)
1. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration.
Paul S; Dansithong W; Figueroa KP; Scoles DR; Pulst SM
Nat Commun; 2018 Sep; 9(1):3648. PubMed ID: 30194296
[TBL] [Abstract][Full Text] [Related]
2. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2.
Scoles DR; Gandelman M; Paul S; Dexheimer T; Dansithong W; Figueroa KP; Pflieger LT; Redlin S; Kales SC; Sun H; Maloney D; Damoiseaux R; Henderson MJ; Simeonov A; Jadhav A; Pulst SM
J Biol Chem; 2022 Aug; 298(8):102228. PubMed ID: 35787375
[TBL] [Abstract][Full Text] [Related]
3. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
[TBL] [Abstract][Full Text] [Related]
4. Effects of STAU1/staufen1 on autophagy in neurodegenerative diseases.
Pulst SM; Scoles DR; Paul S
Autophagy; 2023 Sep; 19(9):2607-2608. PubMed ID: 36652469
[TBL] [Abstract][Full Text] [Related]
5. Staufen Impairs Autophagy in Neurodegeneration.
Paul S; Dansithong W; Gandelman M; Figueroa KP; Zu T; Ranum LPW; Scoles DR; Pulst SM
Ann Neurol; 2023 Feb; 93(2):398-416. PubMed ID: 36151701
[TBL] [Abstract][Full Text] [Related]
6. Staufen1 in Human Neurodegeneration.
Paul S; Dansithong W; Figueroa KP; Gandelman M; Scoles DR; Pulst SM
Ann Neurol; 2021 Jun; 89(6):1114-1128. PubMed ID: 33745139
[TBL] [Abstract][Full Text] [Related]
7. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
Sen NE; Canet-Pons J; Halbach MV; Arsovic A; Pilatus U; Chae WH; Kaya ZE; Seidel K; Rollmann E; Mittelbronn M; Meierhofer D; De Zeeuw CI; Bosman LWJ; Gispert S; Auburger G
Neurobiol Dis; 2019 Dec; 132():104559. PubMed ID: 31376479
[TBL] [Abstract][Full Text] [Related]
8. ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
Scoles DR; Dansithong W; Pflieger LT; Paul S; Gandelman M; Figueroa KP; Rigo F; Bennett CF; Pulst SM
Hum Mol Genet; 2020 Jun; 29(10):1658-1672. PubMed ID: 32307524
[TBL] [Abstract][Full Text] [Related]
9. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
[TBL] [Abstract][Full Text] [Related]
10. Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model.
Dansithong W; Paul S; Figueroa KP; Rinehart MD; Wiest S; Pflieger LT; Scoles DR; Pulst SM
PLoS Genet; 2015 Apr; 11(4):e1005182. PubMed ID: 25902068
[TBL] [Abstract][Full Text] [Related]
11. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
Costa RG; Conceição A; Matos CA; Nóbrega C
Cell Death Dis; 2024 Jun; 15(6):415. PubMed ID: 38877004
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar Ataxia Type 2.
Scoles DR; Pulst SM
Adv Exp Med Biol; 2018; 1049():175-195. PubMed ID: 29427103
[TBL] [Abstract][Full Text] [Related]
13. The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
Koppenol R; Conceição A; Afonso IT; Afonso-Reis R; Costa RG; Tomé S; Teixeira D; da Silva JP; Côdesso JM; Brito DVC; Mendonça L; Marcelo A; Pereira de Almeida L; Matos CA; Nóbrega C
Brain; 2023 Jun; 146(6):2346-2363. PubMed ID: 36511898
[TBL] [Abstract][Full Text] [Related]
14. Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Halbach MV; Stehning T; Damrath E; Jendrach M; Şen NE; Başak AN; Auburger G
PLoS One; 2015; 10(3):e0121089. PubMed ID: 25790475
[TBL] [Abstract][Full Text] [Related]
15. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
Canet-Pons J; Sen NE; Arsović A; Almaguer-Mederos LE; Halbach MV; Key J; Döring C; Kerksiek A; Picchiarelli G; Cassel R; René F; Dieterlé S; Fuchs NV; König R; Dupuis L; Lütjohann D; Gispert S; Auburger G
Neurobiol Dis; 2021 May; 152():105289. PubMed ID: 33577922
[TBL] [Abstract][Full Text] [Related]
16. Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels.
Sen NE; Drost J; Gispert S; Torres-Odio S; Damrath E; Klinkenberg M; Hamzeiy H; Akdal G; Güllüoğlu H; Başak AN; Auburger G
Neurobiol Dis; 2016 Dec; 96():115-126. PubMed ID: 27597528
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous ALS and SCA2 associated with an intermediate-length
Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
[TBL] [Abstract][Full Text] [Related]
19. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate.
Fittschen M; Lastres-Becker I; Halbach MV; Damrath E; Gispert S; Azizov M; Walter M; Müller S; Auburger G
Neurogenetics; 2015 Jul; 16(3):181-92. PubMed ID: 25721894
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2.
Egorova PA; Bezprozvanny IB
Cerebellum; 2022 Oct; 21(5):742-749. PubMed ID: 34978024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
